Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
4.020
+0.030 (0.75%)
At close: Nov 4, 2026, 4:00 PM EST
3.840
-0.180 (-4.48%)
After-hours: Nov 4, 2026, 7:30 PM EST
Zura Bio Employees
Zura Bio had 40 employees as of December 31, 2025. The number of employees increased by 10 or 33.33% compared to the previous year. That makes Zura Bio the 36,008th largest employer in the world and 4,939th in the United States.
Employees
40
Change (1Y)
10
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,055,825
Market Cap
387.23M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 40 | 10 | 33.33% | 40 | 0 |
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Lyell Immunopharma | 161 |
| Allogene Therapeutics | 152 |
| MapLight Therapeutics | 133 |
| C4 Therapeutics | 104 |
| Assembly Biosciences | 73 |
| Tectonic Therapeutic | 60 |
| Altimmune | 57 |
ZURA News
- 8 days ago - Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 8 days ago - Zura Bio files $700M mixed securities shelf - TheFly
- 8 days ago - Wedbush would be ‘aggressive buyer’ of Zura Bio ahead of key Q4 catalyst - TheFly
- 8 days ago - Zura Bio Registration statement: Registration filing - Filings
- 8 days ago - Zura Bio reports Q3 EPS (20c), consensus (21c) - TheFly
- 8 days ago - Zura Bio sees cash runway through at least the end of 2028 - TheFly
- 8 days ago - Zura Bio Reports Third Quarter 2026 Financial Results and Recent Corporate Updates - Business Wire
- 8 days ago - Zura Bio Quarterly report: Q3 2026 - Filings